glp-1 treatment for newly diagnosed diabetes guidelines Impact: How GLP-1s Are Changing the Paradigm Compare GLP-1 Options | Ozempic

Insurance coverage decisions typically require demonstration of obesity through BMI thresholds with or without metabolic comorbidities but do not specifically require established cardiovascular disease

The new 5-HT hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression

Again, similar to the results observed in mouse caSMCs, GLP-1(2836) activated PKA and conferred cytoprotection against oxidative stress injury in human caSMCs (Supplemental Figure 8, A and B)

Have complex or high-risk medical conditions - Patients with unstable cardiovascular disease, advanced kidney disease, recurrent pancreatitis, gastroparesis, or complex medication regimens may require closer in-person monitoring

It requires a collaborative approach with your healthcare team